Parag Saxena, Managing Partner and CEO of INVESCO Private Capital, is a seasoned venture capitalist with more than 20 years of experience. Parag has been involved in over 300 private transactions helping numerous private companies become public companies.

Parag led INVESCO's investments in Amber Networks (sold to Nokia), DiscoveRx, BizRate, Elusys Therapeutics, EndForce, MetroPCS and Xenon Genetics as well as the following, which have gone public: Alkermes, ARM Holdings, Celgene, Indigo, Transgenomic and Volterra. Parag serves on the partnership advisory boards for Accel, Kiwi I Ventures and Skyline Venture Partners. He is also on the board of Transgenomic and several private company boards.
In 1983, Parag joined Citicorp Investment Management, a predecessor firm of INVESCO. He built a $1.5 billion small-cap group with a top-decile record prior to co-founding the private capital group. His career began in 1978 at Becton Dickinson as a product manager. He was later recruited by Booz, Allen and Hamilton to join their Technology Management Services Group focusing on business strategy development.

Parag received an M.B.A. from the Wharton School of the University of Pennsylvania in 1982. He earned a B.Tech from The Indian Institute of Technology in 1977, and a M.S. in Chemical Engineering from the West Virginia College of Graduate Studies in 1978. He is registered with the NASD as a General Securities Representative (Series 7).